COVID-19 vaccines and neglected pregnancy.
作者信息
Dashraath Pradip, Nielsen-Saines Karin, Madhi Shabir A, Baud David
机构信息
Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, National University Hospital, Singapore.
Division of Infectious Diseases, Department of Pediatrics, David Geffen UCLA School of Medicine, Los Angeles, CA, USA.
出版信息
Lancet. 2020 Sep 5;396(10252):e22. doi: 10.1016/S0140-6736(20)31822-5. Epub 2020 Aug 27.
Abstract
摘要
相似文献
1
COVID-19 vaccines and neglected pregnancy.
Lancet. 2020 Sep 5;396(10252):e22. doi: 10.1016/S0140-6736(20)31822-5. Epub 2020 Aug 27.
2
[Not Available].
MMW Fortschr Med. 2020 Apr;162(7):56. doi: 10.1007/s15006-020-0398-7.
3
A vaccine is not too far for COVID-19.
J Infect Dev Ctries. 2020 May 31;14(5):450-453. doi: 10.3855/jidc.12744.
4
US Adults' Preferences for Public Allocation of a Vaccine for Coronavirus Disease 2019.
JAMA Netw Open. 2020 Sep 1;3(9):e2023020. doi: 10.1001/jamanetworkopen.2020.23020.
5
COVID-19 disrupts vaccine delivery.
Lancet Infect Dis. 2020 May;20(5):546. doi: 10.1016/S1473-3099(20)30304-2. Epub 2020 Apr 17.
6
Audio Interview: New SARS-CoV-2 Vaccine Results, with Peter Piot.
N Engl J Med. 2020 Jul 30;383(5):e57. doi: 10.1056/NEJMe2026514.
7
Audio Interview: Covid-19 Vaccine Development.
N Engl J Med. 2020 Jul 16;383(3):e40. doi: 10.1056/NEJMe2025293.
8
COVID-19 vaccines for all?
Lancet. 2020 Jun 13;395(10240):1822-1823. doi: 10.1016/S0140-6736(20)31354-4.
9
COVID-19 and mRNA Vaccines-First Large Test for a New Approach.
JAMA. 2020 Sep 22;324(12):1125-1127. doi: 10.1001/jama.2020.16866.
10
COVID-19 vaccine development pipeline gears up.
Lancet. 2020 Jun 6;395(10239):1751-1752. doi: 10.1016/S0140-6736(20)31252-6.
引用本文的文献
1
How COVID-19 Treatment in Pregnancy Reflects Healthcare Utilization During a Pandemic: A Two-Stage Individual Participant Data Meta-Analysis Combining Case-Based Registries.
Pharmacoepidemiol Drug Saf. 2025 Jul;34(7):e70180. doi: 10.1002/pds.70180.
2
Resilience and preparedness of hospitals for pandemics: Lessons learned from COVID-19.
Jamba. 2024 Oct 16;16(2):1804. doi: 10.4102/jamba.v16i2.1804. eCollection 2024.
3
COVID-19 vaccine hesitancy among pregnant women in an antenatal clinic in Durban, South Africa.
S Afr J Infect Dis. 2023 Aug 31;38(1):516. doi: 10.4102/sajid.v38i1.516. eCollection 2023.
4
Minimal mRNA uptake and inflammatory response to COVID-19 mRNA vaccine exposure in human placental explants.
iScience. 2023 Aug 7;26(9):107549. doi: 10.1016/j.isci.2023.107549. eCollection 2023 Sep 15.
5
Attitudes Toward COVID-19 Vaccination Among Pregnant Persons in Urban Hospital-Affiliated Practices: Exploring Themes in Vaccine Hesitancy.
Matern Child Health J. 2023 Oct;27(10):1855-1863. doi: 10.1007/s10995-023-03752-y. Epub 2023 Jul 24.
6
Evolution of National Guidelines on Medicines Used to Treat COVID-19 in Pregnancy in 2020-2022: A Scoping Review.
J Clin Med. 2023 Jul 6;12(13):4519. doi: 10.3390/jcm12134519.
7
COVID-19 Vaccination during Pregnancy and Lactation: Attitudes and Uptakes before and after Official Recommendations in Germany.
Vaccines (Basel). 2023 Mar 10;11(3):627. doi: 10.3390/vaccines11030627.
8
Minimal mRNA uptake and inflammatory response to COVID-19 mRNA vaccine exposure in human placental explants.
medRxiv. 2023 Feb 2:2023.02.01.23285349. doi: 10.1101/2023.02.01.23285349.
9
"Maternal Vaccination Greatly Depends on Your Trust in the Healthcare System": A Qualitative Study on the Acceptability of Maternal Vaccines among Pregnant Women and Healthcare Workers in Barcelona, Spain.
Vaccines (Basel). 2022 Nov 25;10(12):2015. doi: 10.3390/vaccines10122015.
10
Maternal and neonatal safety of COVID-19 vaccination during the peri-pregnancy period: A prospective study.
J Med Virol. 2023 Jan;95(1):e28378. doi: 10.1002/jmv.28378.
本文引用的文献
1
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet. 2020 Aug 15;396(10249):479-488. doi: 10.1016/S0140-6736(20)31605-6. Epub 2020 Jul 20.
2
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Lancet. 2020 Aug 15;396(10249):467-478. doi: 10.1016/S0140-6736(20)31604-4. Epub 2020 Jul 20.
3
Change in the Incidence of Stillbirth and Preterm Delivery During the COVID-19 Pandemic.
JAMA. 2020 Jul 10;324(7):705-6. doi: 10.1001/jama.2020.12746.
4
Characteristics of Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status - United States, January 22-June 7, 2020.
MMWR Morb Mortal Wkly Rep. 2020 Jun 26;69(25):769-775. doi: 10.15585/mmwr.mm6925a1.
5
Public Health Agency of Sweden's Brief Report: Pregnant and postpartum women with severe acute respiratory syndrome coronavirus 2 infection in intensive care in Sweden.
Acta Obstet Gynecol Scand. 2020 Jul;99(7):819-822. doi: 10.1111/aogs.13901. Epub 2020 Jun 13.
6
Safety and efficacy of ChAdOx1 RVF vaccine against Rift Valley fever in pregnant sheep and goats.
NPJ Vaccines. 2019 Oct 18;4:44. doi: 10.1038/s41541-019-0138-0. eCollection 2019.
7
A Gorilla Adenovirus-Based Vaccine against Zika Virus Induces Durable Immunity and Confers Protection in Pregnancy.
Cell Rep. 2019 Sep 3;28(10):2634-2646.e4. doi: 10.1016/j.celrep.2019.08.005.
Zotero 插件